C-1a

N/A

Report date: 2025/03/14 16:30:49
NME

Base Information

Drug NameC-1a
Drug Alias NameBRAF protein kinase inhibitor (VHIO)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerine/threonine-protein kinase B-raf inhibitors
TargetsSerine/threonine-protein kinase B-raf
Therapy Area/IndicationsMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVall d'Hebron Institut d'Oncologia
China Registration ClassN/A

Develop Information

Active CompaniesRoche Pharmaceutical Research and Early DevelopmentVall d'Hebron Institut d'Oncologia
Inactive CompaniesN/A
Active IndicationsMelanoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A